BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Day In Review: Rampant Deal Activity In Biotech


10/17/2006 4:59:28 PM

October 17, 2006 -- Lilly bid $2.1 billion for ICOS, its partner on the erectile dysfunction drug Cialis; InterMune partnered its protease inhibitor program, including a hepatitis C drug, with Roche; Genzyme trumped the Millennium bid for AnorMED; Merck won FDA approval for Januvia, its oral diabetes drug; Memory Pharma said its Alzheimer's drug is on clinical hold pending FDA review of toxicology reports; the FDA accepted the new drug application for an extended release version of Zyflo , an asthma drug from Critical Therapeutics; and Inovio acquired DNA delivery and expression technology from Valentis. The Centient Biotech 200™ closed with a fractional gain at 3947, an increase of .01%. More details...


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES